A recent Oncomine database analysis revealed higher expression levels of S100A16 in human pancreatic cancer tissues than in normal control tissues, and that the prognosis of patients with high levels of S100A16 was less favorable compared to that of patients with lower levels of S100A16 [53]. This evidence concerns the gene S100A16 and familial pancreatic carcinoma.